Highlight

  • New Arrivals
  • Sale
  • Hot items
New

GLIFEMPA-LIN TABS 30’S

Login to view prices

GALG020

Description

Glifempa-Lin Tablets (30’s)

Glifempa-Lin is a combination oral antidiabetic medication containing Empagliflozin (SGLT2 inhibitor) and Linagliptin (DPP-4 inhibitor). It is used to improve glycemic control in adults with type 2 diabetes mellitus.


Key Features:

  • Dual-action formula: Empagliflozin reduces glucose reabsorption in the kidneys, while Linagliptin increases insulin secretion and decreases glucagon levels.

  • Once-daily oral dosing for simplicity and better adherence.

  • Helps in reducing HbA1c, fasting, and postprandial glucose levels.

  • Weight-neutral or mildly reducing; low risk of hypoglycemia when used alone.

  • May offer added cardiovascular and renal benefits in high-risk patients.


Indications:

  • Management of type 2 diabetes mellitus in adults as an adjunct to diet and exercise.

  • For patients inadequately controlled on either Empagliflozin or Linagliptin alone or in combination with other antidiabetic drugs.


Dosage & Administration:

  • One tablet once daily, with or without food.

  • Dosage to be individualized based on clinical response and renal function.

  • Regular blood glucose and kidney function monitoring is advised.


Precautions:

  • Not for type 1 diabetes or diabetic ketoacidosis.

  • Monitor for signs of urinary/genital infections and pancreatitis.

  • Use cautiously in renal impairment.

  • Inform healthcare provider about all medications in use.


Possible Side Effects:

  • Urinary tract or genital infections

  • Headache, nausea, or mild gastrointestinal symptoms

  • Rare: ketoacidosis or pancreatitis

  • Low risk of hypoglycemia unless combined with insulin or sulfonylureas


Storage:

  • Store below 25°C in a dry place, away from direct sunlight.

  • Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “GLIFEMPA-LIN TABS 30’S”

Your email address will not be published. Required fields are marked *

Select Your Location: